SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
31,64
08-мая-25 14:11:57
15 мин. задержка
Акции
+0,70
+2,26%
Сегодняшний диапазон
30,44 - 31,91
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Supernus to Host First Quarter 2021 Financial Results Conference Call
27 апр 2021 17:44:01 Источник Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
02 апр 2021 16:58:32 Источник Nasdaq GlobeNewswire
-
Supernus to Present at Cowen Healthcare Conference
26 фев 2021 09:00:00 Источник Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
25 фев 2021 16:00:00 Источник Nasdaq GlobeNewswire
-
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
23 фев 2021 09:00:00 Источник Nasdaq GlobeNewswire
-
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
08 фев 2021 09:00:00 Источник Nasdaq GlobeNewswire
-
Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference
06 янв 2021 17:29:08 Источник Nasdaq GlobeNewswire